SEC Filings
Novavax Earns $125 Million From Sanofi After Fifth Patient Is Dosed In Flu-COVID Trial
Two more milestones, $75 million and $225 million, remain under the Sanofi deal, plus royalties on sales.
NVAX
Novavax (NVAX) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
Novavax Holder Himanshu Shah Says His 6.46% Stake No Longer Aims To Influence Control
Shah withdrew his firm's adviser registration, moved to a family office and plans to report the stake on a passive form.
SEC Filings
Himanshu Shah's Firm Discloses 6.46% Passive Stake In Novavax, 10,656,964 Shares
A Schedule 13G lists Shah Capital Management, its fund and Shah as holders, and certifies no aim to influence control.